Published in J Pharmacol Exp Ther on November 01, 2001
Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol (2008) 1.90
Colonic microbiome is altered in alcoholism. Am J Physiol Gastrointest Liver Physiol (2012) 1.79
Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol (2008) 1.76
Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res (2009) 1.75
Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol (2008) 1.63
Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol (2006) 1.61
Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol (2009) 1.52
Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One (2013) 1.48
Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development. World J Gastroenterol (2010) 1.45
MicroRNAs: master regulators of ethanol abuse and toxicity? Alcohol Clin Exp Res (2010) 1.44
The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction. Am J Physiol Gastrointest Liver Physiol (2010) 1.23
Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice. Hepatology (2013) 1.18
The effect of inflammatory cytokines in alcoholic liver disease. Mediators Inflamm (2013) 1.18
Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage. Alcohol Clin Exp Res (2009) 1.15
Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am J Pathol (2011) 1.14
Tumor necrosis factor-α and Muc2 mucin play major roles in disease onset and progression in dextran sodium sulphate-induced colitis. PLoS One (2011) 1.11
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Front Physiol (2012) 1.07
Alcoholic liver injury: influence of gender and hormones. World J Gastroenterol (2010) 1.06
Role of intestinal circadian genes in alcohol-induced gut leakiness. Alcohol Clin Exp Res (2011) 1.00
Advances in alcoholic liver disease. Curr Gastroenterol Rep (2011) 0.98
Milk osteopontin, a nutritional approach to prevent alcohol-induced liver injury. Am J Physiol Gastrointest Liver Physiol (2013) 0.96
Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World J Hepatol (2012) 0.95
Oats supplementation prevents alcohol-induced gut leakiness in rats by preventing alcohol-induced oxidative tissue damage. J Pharmacol Exp Ther (2009) 0.93
Role of mitochondria in alcoholic liver disease. World J Gastroenterol (2014) 0.93
Acute alcohol-induced liver injury. Front Physiol (2012) 0.90
Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma. Life Sci (2012) 0.89
The Role of miR-212 and iNOS in Alcohol-Induced Intestinal Barrier Dysfunction and Steatohepatitis. Alcohol Clin Exp Res (2015) 0.87
Functional roles of protein nitration in acute and chronic liver diseases. Oxid Med Cell Longev (2014) 0.85
Micro-RNA-155 deficiency prevents alcohol-induced serum endotoxin increase and small bowel inflammation in mice. Alcohol Clin Exp Res (2014) 0.85
Increasing whole grain intake as part of prevention and treatment of nonalcoholic Fatty liver disease. Int J Endocrinol (2013) 0.84
Dynamic changes of capillarization and peri-sinusoid fibrosis in alcoholic liver diseases. World J Gastroenterol (2004) 0.81
Alcohol and the Intestine. Biomolecules (2015) 0.80
Effect of daily consumption of probiotic yoghurt on serum levels of calcium, iron and liver enzymes in pregnant women. Int J Prev Med (2013) 0.79
Alterations of the gut microbiome and metabolome in alcoholic liver disease. World J Gastrointest Pathophysiol (2014) 0.79
Intestinal CYP2E1: A mediator of alcohol-induced gut leakiness. Redox Biol (2014) 0.78
Circadian rhythms, alcohol and gut interactions. Alcohol (2014) 0.78
Preventing Gut Leakiness and Endotoxemia Contributes to the Protective Effect of Zinc on Alcohol-Induced Steatohepatitis in Rats. J Nutr (2015) 0.77
Role of CYP2E1 in mitochondrial dysfunction and hepatic tissue injury in alcoholic and non-alcoholic diseases. Curr Mol Pharmacol (2015) 0.77
Reversal of glucose intolerance in rat offspring exposed to ethanol before birth through reduction of nuclear skeletal muscle HDAC expression by the bile acid TUDCA. Physiol Rep (2014) 0.76
Assessment of the Effects of 6 Standard Rodent Diets on Binge-Like and Voluntary Ethanol Consumption in Male C57BL/6J Mice. Alcohol Clin Exp Res (2015) 0.76
The link between inflammation, bugs, the intestine and the brain in alcohol dependence. Transl Psychiatry (2017) 0.75
Insulin resistance in clinical and experimental alcoholic liver disease. Ann N Y Acad Sci (2015) 0.75
Alcohol and Gut-Derived Inflammation. Alcohol Res (2017) 0.75
Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res (2001) 3.29
Why climb a ladder when you can take the elevator? Plast Reconstr Surg (2000) 2.25
Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol (1999) 2.22
Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. J Virol (1992) 1.81
Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene (2008) 1.76
Pseudomelanosis duodeni: associated with multiple clinical conditions and unpredictable iron stainability - a case series. Endoscopy (2008) 1.75
Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology (2000) 1.73
Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation (1999) 1.62
Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci U S A (1992) 1.61
Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut (2003) 1.55
Human glutamine phosphoribosylpyrophosphate amidotransferase. Kinetic and regulatory properties. J Biol Chem (1973) 1.53
Proposed changes for NIH's Center for Scientific Review. Panel on Scientific Boundaries for Review. Center for Scientific Review Advisory Committee, National Institutes of Health. Science (1999) 1.52
Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy. J Clin Gastroenterol (2001) 1.49
Herpes simplex virus hepatitis: expanding the spectrum of disease. Transpl Infect Dis (2006) 1.46
Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med (1999) 1.44
Symmetric division of cancer stem cells--a key mechanism in tumor growth that should be targeted in future therapeutic approaches. Clin Pharmacol Ther (2007) 1.44
The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am J Gastroenterol (1994) 1.41
Burns due to anti-lice lotion. Burns (1999) 1.40
Angiographic patterns of in-stent restenosis and implications on subsequent revascularization. Catheter Cardiovasc Interv (2000) 1.40
Rotational atherectomy: improved procedural outcome with evolution of technique and equipment. Single-center results of first 1,000 patients. Catheter Cardiovasc Interv (1999) 1.40
5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells. J Biol Chem (1985) 1.40
Characterization of the human and rat myoadenylate deaminase genes. J Biol Chem (1990) 1.40
Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest dog. Am J Physiol (1982) 1.39
Use of a grid to simplify botulinum toxin injection for axillary hyperhidrosis. Plast Reconstr Surg (2003) 1.39
Rapid separation of tryptophan, kynurenines, and indoles using reversed-phase high-performance liquid chromatography. J Chromatogr (1979) 1.38
Delusional parasitosis: a clinical profile. Int J Psychiatry Med (2000) 1.36
Implementation of the fit body and soul, a church-based life style program for diabetes prevention in high-risk African Americans: a feasibility study. Diabetes Educ (2010) 1.35
Computer modeling implicates stem cell overproduction in colon cancer initiation. Cancer Res (2001) 1.35
Neurotransmitter receptor alterations in Parkinson's disease. Life Sci (1977) 1.34
Determination of protein carbonyl groups by immunoblotting. Anal Biochem (1999) 1.32
Genetic characterisation of Toxoplasma gondii in wildlife from North America revealed widespread and high prevalence of the fourth clonal type. Int J Parasitol (2011) 1.30
Cardiac muscarinic cholinergic receptors. Biochemical identification and characterization. J Biol Chem (1978) 1.28
Effects of hydrogen sulfide exposure on lung mitochondrial respiratory chain enzymes in rats. Toxicol Appl Pharmacol (1990) 1.28
The enzymatic synthesis of 5-amino-4-imidazolecarboxamide riboside triphosphate (ZTP). Science (1984) 1.26
Prostatic levels of tocopherols, carotenoids, and retinol in relation to plasma levels and self-reported usual dietary intake. Am J Epidemiol (2000) 1.24
Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms. J Pharmacol Exp Ther (1999) 1.24
Metabolism of 5-amino-4-imidazolecarboxamide riboside in cardiac and skeletal muscle. Effects on purine nucleotide synthesis. J Biol Chem (1982) 1.23
Reversal of creatine kinase translational repression by 3' untranslated sequences. Science (1990) 1.21
Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction. J Pharmacol Exp Ther (2000) 1.20
The role of protein kinase C isoforms in modulating injury and repair of the intestinal barrier. J Pharmacol Exp Ther (2005) 1.18
Studies on the exaggerated natriuretic response to a saline infusion in the hypothyroid rat. J Clin Invest (1970) 1.17
Aspiration of the asymptomatic metatarsophalangeal joint in gout patients and hyperuricemic controls. Arthritis Rheum (1982) 1.13
iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am J Physiol Gastrointest Liver Physiol (2001) 1.13
Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins. Gut (2006) 1.11
Characterization of purified human liver acid beta-D-galactosidases A2 and A3. Biochem J (1978) 1.10
Multifocal granular cell tumor of the esophagus and proximal stomach with infiltrative pattern: a case report and review of the literature. Arch Pathol Lab Med (1999) 1.09
Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. Am J Gastroenterol (2001) 1.08
Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. J Clin Invest (1984) 1.08
The phosphoprotein of rabies virus is phosphorylated by a unique cellular protein kinase and specific isomers of protein kinase C. J Virol (2000) 1.08
Separation of glycoprotein-derived oligosaccharides by thin-layer chromatography. Anal Biochem (1979) 1.08
Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect. J Clin Invest (1993) 1.07
NF-kappaB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium. Alcohol (2007) 1.07
Heterogeneity of monoclonal antibody-reactive epitopes on mycobacterial 30-kilodalton-region proteins and the secreted antigen 85 complex and demonstration of antigen 85B on the Mycobacterium leprae cell wall surface. Infect Immun (1992) 1.06
Simple tie-over: the herniotomy approach. Plast Reconstr Surg (1999) 1.06
High prevalence and genotypes of Toxoplasma gondii isolated from organic pigs in northern USA. Vet Parasitol (2012) 1.06
Oxidant-induced intestinal barrier disruption and its prevention by growth factors in a human colonic cell line: role of the microtubule cytoskeleton. Free Radic Biol Med (2000) 1.04
theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability. J Pharmacol Exp Ther (2005) 1.04
Adenylate deaminase. A multigene family in humans and rats. J Biol Chem (1990) 1.04
Human glutamine phosphoribosylpyrophosphate amidotransferase. Two molecular forms interconvertible by purine ribonucleotides and phosphoribosylpyrophosphate. J Biol Chem (1973) 1.04
Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis. Gut (1993) 1.04
Hypoxanthine phosphoribosyltransferase deficiency: association of reduced catalytic activity with reduced levels of immunologically detectable enzyme protein. Proc Natl Acad Sci U S A (1975) 1.03
Nitric oxide synthase in circulating vs. extravasated polymorphonuclear leukocytes. J Leukoc Biol (1995) 1.03
Accelerated repletion of ATP and GTP pools in postischemic canine myocardium using a precursor of purine de novo synthesis. Circ Res (1982) 1.03
Myoepithelial hamartoma of the duodenal wall. Virchows Arch (1998) 1.03
Regulation of oxidant-induced intestinal permeability by metalloprotease-dependent epidermal growth factor receptor signaling. J Pharmacol Exp Ther (2007) 1.03
Genetic characterization of viable Toxoplasma gondii isolates from stray dogs from Giza, Egypt. Vet Parasitol (2012) 1.03
Leiomyosarcoma of the pancreas. HPB (Oxford) (2001) 1.02
Disruption of the purine nucleotide cycle by inhibition of adenylosuccinate lyase produces skeletal muscle dysfunction. J Clin Invest (1984) 1.01
Role of NH(2)- and COOH-terminal domains of the P protein of human parainfluenza virus type 3 in transcription and replication. J Virol (2000) 1.01
Dhat syndrome--culture bound sex neurosis. Indian J Med Sci (1998) 1.00
Human IMP dehydrogenase. Kinetics and regulatory properties. Biochim Biophys Acta (1974) 1.00
Moonshine and lead. Relationship to the pathogenesis of hyperuricemia in gout. Arthritis Rheum (1983) 1.00
Biochemical and cytologic alterations in the respiratory tract of rats exposed for 4 hours to hydrogen sulfide. Fundam Appl Toxicol (1987) 0.98
Novel effect of NF-kappaB activation: carbonylation and nitration injury to cytoskeleton and disruption of monolayer barrier in intestinal epithelium. Am J Physiol Cell Physiol (2004) 0.98
The delta-isoform of protein kinase C causes inducible nitric-oxide synthase and nitric oxide up-regulation: key mechanism for oxidant-induced carbonylation, nitration, and disassembly of the microtubule cytoskeleton and hyperpermeability of barrier of intestinal epithelia. J Pharmacol Exp Ther (2003) 0.98
Evidence for sequential expression of multiple AMP deaminase isoforms during skeletal muscle development. Proc Natl Acad Sci U S A (1987) 0.97
Disruption of the purine nucleotide cycle. A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency. J Clin Invest (1980) 0.97
Molecular analysis of the myoadenylate deaminase deficiencies. Neurology (1992) 0.97
Human parainfluenza virus type 3 inhibits gamma interferon-induced major histocompatibility complex class II expression directly and by inducing alpha/beta interferon. J Virol (2001) 0.96
Evidence that nuclear factor-kappa B activation is critical in oxidant-induced disruption of the microtubule cytoskeleton and barrier integrity and that its inactivation is essential in epidermal growth factor-mediated protection of the monolayers of intestinal epithelia. J Pharmacol Exp Ther (2003) 0.96
Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine. Proc Natl Acad Sci U S A (1990) 0.96
Human neutrophil functions are inhibited in vitro by clinically relevant ethanol concentrations. Alcohol Clin Exp Res (1996) 0.96
Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant (1996) 0.95
Purification and properties of acid beta-galactosidase from feline liver. Biochemistry (1979) 0.95
Antisense RNA complementary to 3' coding and noncoding sequences of creatine kinase is a potent inhibitor of translation in vivo. Proc Natl Acad Sci U S A (1989) 0.95
Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J Toxicol Environ Health A (2003) 0.94
Aminoimidazole carboxamide ribonucleoside toxicity: a model for study of pyrimidine starvation. J Cell Physiol (1981) 0.94
Expression of three stage-specific transcripts of AMP deaminase during myogenesis. Mol Cell Biol (1989) 0.94
Prostatic levels of fatty acids and the histopathology of localized prostate cancer. J Urol (2000) 0.93
Editorial: The kidney and uric acid excretion in man. Kidney Int (1972) 0.93
Mitomycin C-induced colitis in rats: a new animal model of acute colonic inflammation implicating reactive oxygen species. J Lab Clin Med (1992) 0.92